These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7665722)

  • 21. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.
    Adedoyin A; Aarons L; Houston JB
    Drug Metab Dispos; 1987; 15(1):127-32. PubMed ID: 2881749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of age on antipyrine metabolism by liver microsomes isolated from phenobarbital-treated rats.
    Henderson DJ; van Bezooijen CF
    Mech Ageing Dev; 1989 Sep; 49(3):287-94. PubMed ID: 2811495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bioavailability of isoniazid in healthy volunteers--fast and slow INH acetylators].
    Augustynowicz-Kopeć E; Zwolska Z; Niemirowska-Mikulska H
    Pneumonol Alergol Pol; 2002; 70(3-4):167-79. PubMed ID: 12271964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster.
    Hein DW; Doll MA; Nerland DE; Fretland AJ
    Mol Carcinog; 2006 Apr; 45(4):230-8. PubMed ID: 16482518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of age on the oxidative metabolism of antipyrine by uninduced microsomal fractions of rat liver.
    Van Geel CA; Van Bezooijen CF
    Mech Ageing Dev; 1990 Apr; 53(2):169-77. PubMed ID: 2342384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The S-acetyl coenzyme A-dependent metabolic activation of the carcinogen N-hydroxy-2-aminofluorene by human liver cytosol and its relationship to the aromatic amine N-acetyltransferase phenotype.
    Flammang TJ; Yamazoe Y; Guengerich FP; Kadlubar FF
    Carcinogenesis; 1987 Dec; 8(12):1967-70. PubMed ID: 3677322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of enzyme induction on antipyrine metabolite formation.
    Danhof M; Verbeek RM; van Boxtel CJ; Boeijinga JK; Breimer DD
    Br J Clin Pharmacol; 1982 Mar; 13(3):379-86. PubMed ID: 7059438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
    Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR
    Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipyrine clearance and metabolism in patients with psoriasis.
    Kubota K; Ishizaki T; Chiba K; Takagi A; Nakagawa A; Nakamura K
    Br J Clin Pharmacol; 1986 Oct; 22(4):455-62. PubMed ID: 3768257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of malaria infection on antipyrine metabolite formation in the rat.
    Mansor SM; Ward SA; Edwards G
    Biochem Pharmacol; 1991 Apr; 41(8):1264-6. PubMed ID: 2009102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
    Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
    Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of antipyrine and rifampin on the metabolism of diazepam.
    Ohnhaus EE; Brockmeyer N; Dylewicz P; Habicht H
    Clin Pharmacol Ther; 1987 Aug; 42(2):148-56. PubMed ID: 3608348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
    Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
    Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in metabolism and urinary excretion of antipyrine induced by aerobic conditioning.
    Villa JG; Bayon JE; González-Gallego J
    J Sports Med Phys Fitness; 1999 Sep; 39(3):197-201. PubMed ID: 10573660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine.
    Siegmund W; Franke G; Wulkow R; Hanke W; Thonack R
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):469-73. PubMed ID: 1813431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes.
    Farrell GC; Cooksley WG; Powell LW
    Clin Pharmacol Ther; 1979 Oct; 26(4):483-92. PubMed ID: 487696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dimethocaine, a synthetic cocaine derivative: studies on its in vitro metabolism catalyzed by P450s and NAT2.
    Meyer MR; Lindauer C; Maurer HH
    Toxicol Lett; 2014 Feb; 225(1):139-46. PubMed ID: 24309420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene.
    Groen K; Breimer DD; van Bezooijen CF
    Drug Metab Dispos; 1992; 20(4):502-6. PubMed ID: 1356725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipyrine clearance and metabolite formation in children with congenital adrenal hyperplasia.
    Teunissen MW; Bruining GJ; De Jongh BM; Tenkate-Westerhof EW; Breimer DD
    Br J Clin Pharmacol; 1985 Dec; 20(6):703-6. PubMed ID: 4092001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.